Patient First
Bringing empathy into the digital environment
Learn best practices to incorporate empathy and human interaction in the digital environment with attentive listening, building relationships with sites, promoting clinical trial technology implementation, and learning from other industries that have successfully transitioned to digital.
New EU Regulatory Recommendations for Decentralized Trials Keep Focus on Patients and Sites
As clinical trials rapidly modernize, government regulators work to evolve even as the same core principles apply. Still, decentralized clinical trials are – simply – clinical trials, as all research today is decentralized in some way, yet we lack global harmonization of regulations.
The digital future is now
Watch the on-demand panel discussion between Medable, Syneos, Illingworth and Veeva, moderated by Gilead, as they discuss how the next generation of clinical development is now.
ePRO Case study: Better options and outcomes oncology trials.
Medable worked with a top 5 pharma company to increase the safety of patients as anti-cancer treatments may cause pulmonary toxicity, ranging from asymptomatic radiological changes to respiratory failure, and is considered a common side effect.
Five myths about eConsent
As our industry continues to follow new paths to digitization, it’s important to debunk the most prevalent myths — both old and new — and reach a deeper understanding of decentralized clinical trials.
ePROs: Transforming oncology research
In this webinar, VP of Digital Trial Solutions Musaddiq Khan, VP of Product Strategy Colin Weller, and Cancer Survivor Lindsey Matt discuss how Medable is supporting a patient-first approach in complex Oncology clinical trials
Everything you need to know about hybrid & decentralized trials
Claire Marsden, Ph.D., VP of DCT Solutions at Medable, and John Galvin, MD, MS, MPH, Senior Medical Director of US Medical Affairs at Incyte, present on the basics of decentralized clinical trials, exploring hybrid and fully decentralized approaches and the advantages of developing patient-centric clinical trials.
Using clear language and the latest technology in informed consent forms (ICFs) for clinical trials
Explore ways to improve the consenting communication process using clear language and the latest technology.
Designing patient-friendly ePRO instruments
This blog explores why patient-centric ePRO instrument design is critical to driving study success, provides tips on how to make instruments more patient-centric, and offers resources for additional ePRO design guidance.
How to write clear and compelling patient recruitment material to drive enrollment and boost diversity
Clinical trials are essential for the development of new medical treatments and devices. However, enrolling patients in clinical trials is one of the most challenging aspects of conducting these studies. This is especially true when it comes to recruiting a diverse and representative patient population.
Meet patients where they are with consent information
The cornerstone of access to any clinical research project is the informed consent process–the decision of a participant to join a study based upon full and complete sharing of information about what the study will require, the risks of participation, and the voluntary nature of that participation.
This isn’t simply the participant’s signature on a paper or electronic form. According to governmental organizations like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), that signature is only part of the process. Of perhaps even greater importance is the provision of information to the patient accompanied by a discussion of the study and a chance to have questions answered, so that the decision can truly be considered “informed.”